Clinical Trials Logo

Brain Damage clinical trials

View clinical trials related to Brain Damage.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04546737 Active, not recruiting - Covid19 Clinical Trials

Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients

NSpectroCovid
Start date: September 8, 2020
Phase: N/A
Study type: Interventional

Viral pandemics, such as HIV and SARS-Cov-V1, have shown that they can lead to acute and / or delayed neurological complications. At the actual context of the pandemic Coronavirus disease 2019 (COVID-19), neurological manifestations seem to be confirmed since in 85% of COVID-19 patients, present neurological symptoms, including anosmia, ageusia, periorbital pain, dizziness, fatigue, even moderate headache, moderate memory and/or behavioral disorders. However, these neurological manifestations are not well studied and their radiological features are not well described. It is therefore important to assess these potential neurological complications in COVID-19 patients. To the investigator knowledge, there is no previous study in the literature describing spectral brain changes in COVID + patients. Thus, the goal of this work is to describe the radiological semiology using MRI and particularly Magnetic Resonance Spectroscopic (MRS) biomarkers in the evaluation of acute and / or delayed brain damage in COVID + patients presenting a neurological manifestations that are initially related to the cranial nerves damage.